lobbying_activities: 2596779
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2596779 | 41e2423a-fc21-4068-b974-eb130f4f3bc7 | Q1 | BROYDRICK & ASSOCIATES | 7268 | EXELA PHARMA SCIENCES | 2021 | first_quarter | PHA | Drug shortages and FDA approval, USTR acceptance. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2021-04-15T18:43:47.097000-04:00 |